ONI BioPharma to Commence Trading on the Over-the-Counter Bulletin Board on Monday, December 22, 2008; ONI BioPharma to Post ...
December 19 2008 - 9:45AM
Business Wire
Oragenics, Inc. d/b/a ONI Biopharma Inc. (the "Company" or "ONI"
AMEX:ONI), an American biopharmaceutical company that has developed
broad-based technologies in oral care, antibiotics, diagnostics and
weight control, today announced that commencing Monday, December
22, 2008, quotations for the Company's shares will be available on
the Over-the-Counter (OTC) Bulletin Board. To the extent a change
in the Company's trading symbol occurs the Company expects to issue
a press release announcing the new symbol. The transition to the
OTC is expected to be seamless to investors. Investors should be
able to trade their ONI shares through their brokers in the same
manner as they had been prior to this date. Stanley B. Stein, Chief
Executive Officer of ONI BioPharma commented, �We are thrilled to
be trading in two markets, the OTC and Alternext Paris, that are
best suited to biotechnology and healthcare companies. We consider
ourselves to be a global company and therefore benefit greatly by
having both a domestic and international trading presence. Our
facilities are headquartered in the US but our outreach is
worldwide. We invite you to listen to our audio release, available
at our website www.onibiopharma.com, which will explain this in
more detail and will be posted in English and in French.� The OTC
Bulletin Board is a quotation service that displays real-time
quotes, last-sale prices and volume information in over-the-counter
securities. The Financial Industry Regulatory Authority (FINRA), a
self-regulatory organization of the securities industry in the
United States, oversees the OTC Bulletin Board. In a separate press
release issued on December 11, 2008, ONI BioPharma announced that
ONI's shares will also be traded on Alternext Paris. The new OTC
Bulletin Board listing will have no impact on the status of ONI's
Alternext Paris listing, which occurred on December 15, 2008. The
Company also announced that later today, it will post on its
website (www.onibiopharma.com) the English version of an audio
release from management that will answer frequently-asked investor
questions on the Company�s strategic plan and the trading of its
shares. The Company expects to post the French version of the
release on its website on December 23, 2008. About ONI BioPharma
Oragenics, Inc. (d/b/a ONI BioPharma Inc.) is a biopharmaceutical
company with a pipeline of unique proprietary technologies, some of
which are being commercialized. The Company also has a number of
products in discovery, preclinical and clinical development, with a
concentration in the main therapeutic area of infectious diseases,
diagnostics, and oral health. The Company has developed platform
technologies with respect to its products, thereby creating a
potential pipeline of future products, which the Company expects to
develop. Forward-looking Statements Safe Harbor Statement Under the
Private Securities Litigation Reform Act of 1995: This press
release includes forward-looking statements that reflect ONI
BioPharma�s current views with respect to future events and
financial performance. These forward-looking statements are based
on management�s beliefs and assumptions and information currently
available. The words �believe,� �expect,� �anticipate,� �intend,�
�estimate,� �project� and similar expressions that do not relate
solely to historical matters identify forward-looking statements.
Investors should be cautious in relying on forward-looking
statements because they are subject to a variety of risks,
uncertainties, and other factors that could cause actual results to
differ materially from those expressed in any such forward-looking
statements. ONI expressly disclaims any responsibility to update
forward-looking statements and draws the attention of investors to
the risk factors described in the Information Document. This press
release does not constitute the offering of any securities for
sale. The Company's securities may not be offered or sold absent
registration under applicable securities laws or an exemption from
registration. Any public offering of the securities of the Company
will be made by means of a prospectus that will contain detailed
information about the offering and the Company.
Oragenics (AMEX:ONI)
Historical Stock Chart
From Sep 2024 to Oct 2024
Oragenics (AMEX:ONI)
Historical Stock Chart
From Oct 2023 to Oct 2024